Biotech Values

[dav1234]

makes sense,i would personally want regulators to prevent such anti-competitive behavior,but TEVA are clever and protecting their Copax cash cow must be their top priority, if they lose half of copax cash to a generic then IMO their divi becomes iffy and that would seriously hurt their pps and reputation.

maybe a direct buyout is unrealistic but another company friendly(loyal) to TEVA could, an israeli billionaire could make an offer ,TEVA could even try to "bribe" its way in by offering to partner (and fund) other drugs with MNTA ( unlikely,unethical but not impossible),back door deal with another pharma to take out MNTA in buyout and slow down MCopax and in return TEVA could slow down on their own competing generics from that Pharama (again unethical,illegal but not impossible)

billions at stake,anything is possible